SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kaname Akamata, Yoshihide Asano, Naohiko Aozasa, Shinji Noda, Takashi Taniguchi, Takehiro Takahashi, Yohei Ichimura, Tetsuo Toyama, Shinichi Sato, Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1, Arthritis Research & Therapy, 2014, 16, 2, R86

    CrossRef

  2. 2
    Takehiro Takahashi, Yoshihide Asano, Eisuke Amiya, Masaru Hatano, Zenshiro Tamaki, Munenori Takata, Atsuko Ozeki, Aya Watanabe, Shuichi Kawarasaki, Takashi Taniguchi, Yohei Ichimura, Tetsuo Toyama, Masafumi Watanabe, Yasunobu Hirata, Ryozo Nagai, Issei Komuro, Shinichi Sato, Clinical correlation of brachial artery flow-mediated dilation in patients with systemic sclerosis, Modern Rheumatology, 2014, 24, 1, 106

    CrossRef

  3. 3
    Sei-ichiro Motegi, Sayaka Toki, Kazuya Yamada, Akihiko Uchiyama, Osamu Ishikawa, Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies, The Journal of Dermatology, 2014, 41, 12
  4. 4
    Hayakazu Sumida, Yoshihide Asano, Masaru Hatano, Naohiko Aozasa, Tetsuo Toyama, Kaname Akamata, Miki Miyazaki, Takashi Taniguchi, Takehiro Takahashi, Yohei Ichimura, Shinji Noda, Yoshihiro Kuwano, Koichi Yanaba, Shinichi Sato, Effect of ambrisentan on peripheral circulation in patients with systemic sclerosis, Modern Rheumatology, 2014, 1

    CrossRef

  5. 5
    Isabel Faust, Kai Böker, Christoph Lichtenberg, Joachim Kuhn, Cornelius Knabbe, Doris Hendig, First description of the complete human xylosyltransferase-I promoter region, BMC Genetics, 2014, 15, 1, 129

    CrossRef

  6. 6
    Yohei Ichimura, Yoshihide Asano, Kaname Akamata, Takehiro Takahashi, Shinji Noda, Takashi Taniguchi, Tetsuo Toyama, Naohiko Aozasa, Hayakazu Sumida, Yoshihiro Kuwano, Koichi Yanaba, Yayoi Tada, Makoto Sugaya, Shinichi Sato, Takafumi Kadono, Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis, Archives of Dermatological Research, 2014, 306, 4, 331

    CrossRef

  7. 7
    Anna M. Piccinini, Kim S. Midwood, Illustrating the interplay between the extracellular matrix and microRNAs, International Journal of Experimental Pathology, 2014, 95, 3
  8. You have free access to this content8
    Hayakazu Sumida, Yoshihide Asano, Zenshiro Tamaki, Naohiko Aozasa, Takashi Taniguchi, Takehiro Takahashi, Tetsuo Toyama, Yohei Ichimura, Shinji Noda, Kaname Akamata, Miki Miyazaki, Yoshihiro Kuwano, Koichi Yanaba, Shinichi Sato, Successful experience of rituximab therapy for systemic sclerosis-associated interstitial lung disease with concomitant systemic lupus erythematosus, The Journal of Dermatology, 2014, 41, 5
  9. 9
    Takehiro Takahashi, Yoshihide Asano, Eisuke Amiya, Masaru Hatano, Zenshiro Tamaki, Munenori Takata, Atsuko Ozeki, Aya Watanabe, Shuichi Kawarasaki, Takashi Taniguchi, Yohei Ichimura, Tetsuo Toyama, Masafumi Watanabe, Yasunobu Hirata, Ryozo Nagai, Issei Komuro, Shinichi Sato, Clinical correlation of brachial artery flow-mediated dilation in patients with systemic sclerosis, Modern Rheumatology, 2013,

    CrossRef

  10. 10
    Yuri Masui, Yoshihide Asano, Takehiro Takahashi, Sayaka Shibata, Kaname Akamata, Naohiko Aozasa, Shinji Noda, Takashi Taniguchi, Yohei Ichimura, Tetsuo Toyama, Zenshiro Tamaki, Hayakazu Sumida, Koichi Yanaba, Yayoi Tada, Makoto Sugaya, Shinichi Sato, Takafumi Kadono, Clinical significance of monitoring serum adiponectin levels during intravenous pulse cyclophosphamide therapy in interstitial lung disease associated with systemic sclerosis, Modern Rheumatology, 2013, 23, 2, 323

    CrossRef

  11. 11
    Yuri Masui, Yoshihide Asano, Takehiro Takahashi, Sayaka Shibata, Kaname Akamata, Naohiko Aozasa, Shinji Noda, Takashi Taniguchi, Yohei Ichimura, Tetsuo Toyama, Zenshiro Tamaki, Hayakazu Sumida, Koichi Yanaba, Yayoi Tada, Makoto Sugaya, Shinichi Sato, Takafumi Kadono, Clinical significance of monitoring serum adiponectin levels during intravenous pulse cyclophosphamide therapy in interstitial lung disease associated with systemic sclerosis, Modern Rheumatology, 2013, 23, 2, 323

    CrossRef

  12. 12
    T. Toyama, Y. Asano, T. Takahashi, N. Aozasa, K. Akamata, S. Noda, T. Taniguchi, Y. Ichimura, H. Sumida, Z. Tamaki, Y. Masui, Y. Tada, M. Sugaya, S. Sato, T. Kadono, Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosis, Journal of the European Academy of Dermatology and Venereology, 2013, 27, 3
  13. 13
    Shinji Noda, Yoshihide Asano, Naohiko Aozasa, Kaname Akamata, Takashi Taniguchi, Takehiro Takahashi, Yohei Ichimura, Tetsuo Toyama, Hayakazu Sumida, Yoshihiro Kuwano, Koichi Yanaba, Yayoi Tada, Makoto Sugaya, Takafumi Kadono, Shinichi Sato, Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis, Archives of Dermatological Research, 2013, 305, 4, 325

    CrossRef

  14. 14
    Takehiro Takahashi, Yoshihide Asano, Kaname Akamata, Naohiko Aozasa, Takashi Taniguchi, Shinji Noda, Yuri Masui, Yohei Ichimura, Tetsuo Toyama, Zenshiro Tamaki, Yayoi Tada, Makoto Sugaya, Takafumi Kadono, Shinichi Sato, Dynamics of serum angiopoietin-2 levels correlate with efficacy of intravenous pulse cyclophosphamide therapy for interstitial lung disease associated with systemic sclerosis, Modern Rheumatology, 2013, 23, 5, 884

    CrossRef

  15. 15
    Takehiro Takahashi, Yoshihide Asano, Kaname Akamata, Naohiko Aozasa, Takashi Taniguchi, Shinji Noda, Yuri Masui, Yohei Ichimura, Tetsuo Toyama, Zenshiro Tamaki, Yayoi Tada, Makoto Sugaya, Takafumi Kadono, Shinichi Sato, Dynamics of serum angiopoietin-2 levels correlate with efficacy of intravenous pulse cyclophosphamide therapy for interstitial lung disease associated with systemic sclerosis, Modern Rheumatology, 2013, 23, 5, 884

    CrossRef

  16. 16
    Jan Kosla, Marta Dvorakova, Michal Dvorak, Vladimir Cermak, Effective myofibroblast dedifferentiation by concomitant inhibition of TGF-β signaling and perturbation of MAPK signaling, European Journal of Cell Biology, 2013, 92, 12, 363

    CrossRef

  17. 17
    Boris Hinz, Matrix mechanics and regulation of the fibroblast phenotype, Periodontology 2000, 2013, 63, 1
  18. 18
    Takashi Matsushita, Manabu Fujimoto, Scleroderma: recent lessons from murine models and implications for future therapeutics, Expert Review of Dermatology, 2013, 8, 5, 527

    CrossRef

  19. 19
    T. Taniguchi, Y. Asano, K. Akamata, N. Aozasa, S. Noda, T. Takahashi, Y. Ichimura, T. Toyama, H. Sumida, Y. Kuwano, K. Yanaba, Y. Tada, M. Sugaya, T. Kadono, S. Sato, Serum levels of ADAM12-S: possible association with the initiation and progression of dermal fibrosis and interstitial lung disease in patients with systemic sclerosis, Journal of the European Academy of Dermatology and Venereology, 2013, 27, 6
  20. You have free access to this content20
    Franco Klingberg, Boris Hinz, Eric S White, The myofibroblast matrix: implications for tissue repair and fibrosis, The Journal of Pathology, 2013, 229, 2
  21. 21
    Xiao-Yong Man, Kenneth W Finnson, Murray Baron, Anie Philip, CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts, Arthritis Research & Therapy, 2012, 14, 3, R144

    CrossRef

  22. 22
    T. Taniguchi, Y. Asano, M. Hatano, Z. Tamaki, M. Tomita, T. Kawashima, M. Miyazaki, H. Sumida, K. Akamata, T. Takahashi, Y. Ichimura, T. Toyama, M. Sugita, S. Noda, A. Yao, K. Kinugawa, S. Sato, Effects of bosentan on nondigital ulcers in patients with systemic sclerosis, British Journal of Dermatology, 2012, 166, 2
  23. 23
    Zenshiro Tamaki, Yoshihide Asano, Masaru Hatano, Atsushi Yao, Tomohiko Kawashima, Manabu Tomita, Koichiro Kinugawa, Ryozo Nagai, Shinichi Sato, Efficacy of low-dose imatinib mesylate for cutaneous involvement in systemic sclerosis: a preliminary report of three cases, Modern Rheumatology, 2012, 22, 1, 94

    CrossRef

  24. 24
    Zenshiro Tamaki, Yoshihide Asano, Masaru Hatano, Atsushi Yao, Tomohiko Kawashima, Manabu Tomita, Koichiro Kinugawa, Ryozo Nagai, Shinichi Sato, Efficacy of low-dose imatinib mesylate for cutaneous involvement in systemic sclerosis: a preliminary report of three cases, Modern Rheumatology, 2012, 22, 1, 94

    CrossRef

  25. 25
    K.W. Frommer, M. Geyer, G.S. Firestein, Intrazelluläre Signaltransduktionswege, Zeitschrift für Rheumatologie, 2012, 71, 6, 460

    CrossRef

  26. 26
    Taeko Nakamura-Wakatsuki, Noritaka Oyama, Toshiyuki Yamamoto, Local injection of latency-associated peptide, a linker propeptide specific for active form of transforming growth factor-beta1, inhibits dermal sclerosis in bleomycin-induced murine scleroderma, Experimental Dermatology, 2012, 21, 3
  27. 27
    Boris Hinz, Mechanical Aspects of Lung Fibrosis, Proceedings of the American Thoracic Society, 2012, 9, 3, 137

    CrossRef

  28. 28
    Minoru Hasegawa, Kazuhiko Takehara, Potential Immunologic Targets for Treating Fibrosis in Systemic Sclerosis: A Review Focused on Leukocytes and Cytokines, Seminars in Arthritis and Rheumatism, 2012, 42, 3, 281

    CrossRef

  29. 29
    Y. Masui, Y. Asano, S. Shibata, S. Noda, N. Aozasa, K. Akamata, D. Yamada, Z. Tamaki, Y. Tada, M. Sugaya, S. Sato, T. Kadono, Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis, Journal of the European Academy of Dermatology and Venereology, 2012, 26, 3
  30. 30
    T. Odani, S. Yasuda, Y. Ota, Y. Fujieda, Y. Kon, T. Horita, Y. Kawaguchi, T. Atsumi, H. Yamanaka, T. Koike, Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB5*01:05 allele in scleroderma patients with interstitial lung disease, Rheumatology, 2012, 51, 10, 1765

    CrossRef

  31. 31
    Léa Castellucci, Sarra E. Jamieson, Lucas Almeida, Joyce Oliveira, Luiz Henrique Guimarães, Marcus Lessa, Michaela Fakiola, Amélia Ribeiro de Jesus, E. Nancy Miller, Edgar M. Carvalho, Jenefer M. Blackwell, Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil, Infection, Genetics and Evolution, 2012, 12, 5, 1102

    CrossRef

  32. 32
    Anna Ludwicka-Bradley, Richard M. Silver, Galina S. Bogatkevich, Coagulation and Autoimmunity in Scleroderma Interstitial Lung Disease, Seminars in Arthritis and Rheumatism, 2011, 41, 2, 212

    CrossRef

  33. 33
    Lukas J. A. C. Hawinkels, Peter ten Dijke, Exploring anti-TGF-β therapies in cancer and fibrosis, Growth Factors, 2011, 29, 4, 140

    CrossRef

  34. 34
    L Castellucci, S E Jamieson, E N Miller, L F de Almeida, J Oliveira, A Magalhães, L H Guimarães, M Lessa, E Lago, A R de Jesus, E M Carvalho, J M Blackwell, FLI1 polymorphism affects susceptibility to cutaneous leishmaniasis in Brazil, Genes and Immunity, 2011, 12, 7, 589

    CrossRef

  35. 35
    Lara Buscemi, David Ramonet, Franco Klingberg, Aurélie Formey, Josiane Smith-Clerc, Jean-Jacques Meister, Boris Hinz, The Single-Molecule Mechanics of the Latent TGF-β1 Complex, Current Biology, 2011, 21, 24, 2046

    CrossRef

  36. 36
    Naoki Iwamoto, Jörg H. W. Distler, Oliver Distler, Tyrosine Kinase Inhibitors in the Treatment of Systemic Sclerosis: From Animal Models to Clinical Trials, Current Rheumatology Reports, 2011, 13, 1, 21

    CrossRef

  37. 37
    Lysianne Follonier Castella, Giulio Gabbiani, Christopher A. McCulloch, Boris Hinz, Regulation of myofibroblast activities: Calcium pulls some strings behind the scene, Experimental Cell Research, 2010, 316, 15, 2390

    CrossRef